AUG 10, 2026 · JOURNAL ARTICLE
A predictive model for immunotherapy efficacy in cancer based on dynamic changes of CD8+ T cells: a pan-cancer retrospective study
Frontiers in Immunology
Retrospective single-cohort study with internal validation showing CD8+ T cell dynamics predict immunotherapy outcomes via a novel risk model, but lacks external validation and prospective design needed to change practice.
Reported
Hazard ratio for decreased CD8+ T…0.2308
95% CI for CD8+ T cell HR0.0875–0.5636
Time-dependent AUC at 2.5 months0.727